drugset / Trial / NCT02628847

Sildenafil and Stroke Recovery

NCT02628847

Phase 1 Terminated 11 enrolled University of Utah
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a small, pilot randomized clinical trial of administering sildenafil citrate to individuals within 10 days of ischemic stroke who have motor impairment and who are undergoing inpatient rehabilitation compared to placebo. The primary outcome is motor recovery at one and three months.

Timeline

Start
2012-03
Primary completion
2016-10
Completion
2016-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg

Indications